Fetal hemoglobin expression in the compound heterozygous state for −117 (G→A) Aγ HPFH and IVSII‐745 (C→G) β+ thalassemia: A case study
George Dedoussis, Klio Sinopoulou, Marilena Gyparaki, Aphroditi Loutradis
Abstract
Open-access reader
George Dedoussis, Klio Sinopoulou, Marilena Gyparaki, Aphroditi Loutradis
Abstract
Open-access reader
We studied a family in which two inherited defects of the non-α-globin cluster segregate: Greek hereditary persistence of fetal hemoglobin (HPFH) and β-thalassemia. The compound heterozygote is a healthy man with 43% HbF, Gγ/Aγ ratio (27:73) differing from that of 10 simple heterozygotes for the Greek HPFH (92:8), normal levels of total Hb (13.3 g/dl), and reduced HbA2 levels comparing with the levels of β-thal heterozygotes for the same mutation. Molecular analysis of the β-globin genotype revealed the presence of the IVSII-745 (C→G) β+ RNA splice mutation in trans with the −117 G→A Greek HPFH. The β+ mutation was linked to haplotype VII and the Greek HPFH was associated with haplotype Ia. The father of the compound heterozygote carries the Greek HPFH in trans with the −158 C→T on the Gγ promoter, which is linked with haplotype IV. He presented 13.5% HbF with a Gγ/Aγ ratio 75:25. His daughter was a compound heterozygote for the IVSII-745 mutation in trans with the −158 C→T, while her HbF levels were 3.7% with a Gγ/Aγ ratio 31:69. Am. J. Hematol. 61:139–143, 1999. © 1999 Wiley-Liss, Inc.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
We studied a family in which two inherited defects of the non-α-globin cluster segregate: Greek hereditary persistence of fetal hemoglobin (HPFH) and β-thalassemia. The compound heterozygote is a healthy man with 43% HbF, Gγ/Aγ ratio (27:73) differing from that of 10 simple heterozygotes for the Greek HPFH (92:8), normal levels of total Hb (13.3 g/dl), and reduced HbA2 levels comparing with the levels of β-thal heterozygotes for the same mutation. Molecular analysis of the β-globin genotype revealed the presence of the IVSII-745 (C→G) β+ RNA splice mutation in trans with the −117 G→A Greek HPFH. The β+ mutation was linked to haplotype VII and the Greek HPFH was associated with haplotype Ia. The father of the compound heterozygote carries the Greek HPFH in trans with the −158 C→T on the Gγ promoter, which is linked with haplotype IV. He presented 13.5% HbF with a Gγ/Aγ ratio 75:25. His daughter was a compound heterozygote for the IVSII-745 mutation in trans with the −158 C→T, while her HbF levels were 3.7% with a Gγ/Aγ ratio 31:69. Am. J. Hematol. 61:139–143, 1999. © 1999 Wiley-Liss, Inc.
Key concepts: Compound heterozygosity, Heterozygote advantage, Fetal hemoglobin, Haplotype, Thalassemia, Genetics, Hemoglobinopathy, Hemoglobin